×
About 113,953 results

Study Confirms Increased CVT With AstraZeneca COVID Vaccine
https://www.medscape.com/viewarticle/976487

Jul 1st, 2022 - A new Scandinavian study has confirmed previous data showing increased rates of cerebral venous thrombosis and thrombocytopenia after the AstraZeneca COVID-19 vaccine. The study also showed higher rates of several thromboembolic and thrombocytopenic outcomes after the Pfizer and Moderna mRNA vaccines, although these increases were less than the rates observed after the AstraZeneca vaccine, and ...

Lifestyle medicine eases anxiety symptoms
https://www.mdedge.com/psychiatry/article/255947/anxiety-disorders/lifestyle-medicine-eases-anxiety-symptoms
Heidi Splete

Jun 30th, 2022 - Lifestyle medicine significantly improved symptoms for patients with anxiety, compared with controls, based on data from a meta-analysis of more than 18,000 individuals. Despite the availability of effective treatment strategies, including pharmacotherapy, psychotherapy, and combination therapy, the prevalence of anxiety continues to increase, especially in low-income and conflict-ridden countr.

Mobile devices ‘addictive by design’: Obesity is one of many health effects
https://www.mdedge.com/endocrinology/article/255924/obesity/mobile-devices-addictive-design-obesity-one-many-health-effects
Ted Bosworth

Jun 30th, 2022 - Wireless devices, like smart phones and tablets, appear to induce compulsive or even addictive use in many individuals, leading to adverse health consequences that are likely to be curtailed only through often difficult behavior modification, according to a pediatric endocrinologist’s take on the problem. While the summary was based in part on the analysis of 234 published papers drawn from the.

US Steps Up Fight Against Monkeypox, Allocates More Vaccines to States
https://www.medscape.com/viewarticle/976347

Jun 30th, 2022 - CHICAGO/WASHINGTON (Reuters) - The U.S. government is ramping up efforts to staunch the spread of monkeypox by sending hundreds of thousands of vaccine doses to states in the coming months, expanding access for those most at risk and increasing supply to areas with high case numbers. The plan, announced on Tuesday, involves rapidly expanding access to doses of Bavarian Nordic's live, nonreplica...

Sanofi Caps Out-of-Pocket Insulin Cost at $35 for Uninsured US Patients
https://www.medscape.com/viewarticle/976396

Jun 30th, 2022 - (Reuters) - French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of insulin, in the wake of heightened public scrutiny over soaring prices of the life-saving drug. Sanofi said the new price, down from the prior out-of-pocket cost of $99, will be effective from July 1. U.S. lawmakers have pulled up healthcare compa...

Irritable Bowel Syndrome Therapy Removed From Market (Again)
https://www.medscape.com/viewarticle/976460

Jun 30th, 2022 - Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from the US market effective June 30, according to the manufacturer, Alfasigma. The Italian pharmaceutical company said the drug is being removed for business purposes, not because of any concern involving its safety or efficacy, nor has it been recalled. The drug has been th...

EU Proposes Ban on Flavoured Heated Tobacco Products
https://www.medscape.com/viewarticle/976352

Jun 30th, 2022 - BRUSSELS (Reuters) - The European Commission proposed on Wednesday to ban the sale in the EU of flavoured heated tobacco products after a big rise in their consumption. "By removing flavoured heated tobacco from the market we are taking yet another step towards realising our vision under Europe's Beating Cancer Plan to create a "Tobacco Free Generation" with less than 5% of the population using...

South Korea Approves First Domestically Developed COVID Vaccine
https://www.medscape.com/viewarticle/976355

Jun 30th, 2022 - SEOUL (Reuters) - South Korea approved its first domestically developed COVID-19 vaccine, manufactured by SK bioscience Co Ltd, for general public use following positive clinical data, authorities said on Wednesday. The SKYCovione vaccine was authorised for a two-dose regimen on people aged 18 or older, with shots given four weeks apart, according to the Ministry of Food and Drug Safety. In a p...

COVID Cases Spike in Americas, South America Worst Hit: PAHO
https://www.medscape.com/viewarticle/976371

Jun 30th, 2022 - SAO PAULO (Reuters) - COVID-19 cases in the Americas rose about 14% last week from the previous one, with 1.3 million new cases and 4,158 new deaths reported, the Pan American Health Organization (PAHO) said on Wednesday. South America was the worst affected, with an increased COVID death rate up 32.8% from previous week, according to PAHO Director Dr. Carissa Etienne. "In South America, there ...

WHO Warns 'Sustained Transmission' of Monkeypox Risks Vulnerable Groups
https://www.medscape.com/viewarticle/976373

Jun 30th, 2022 - LONDON (Reuters) - The World Health Organization says "sustained transmission" of monkeypox worldwide could see the virus begin to move into high-risk groups, such as pregnant women, immunocompromised people and children. WHO said on Wednesday it was investigating reports of infected children, including two cases in Britain, as well as following up reports in Spain and France. None of the cases...

Militants in Pakistan Attack Polio Vaccination Team, Killing Three
https://www.medscape.com/viewarticle/976302

Jun 29th, 2022 - PESHAWAR, Pakistan (Reuters) - Unidentified militants opened fire on a polio vaccination team in Pakistan on Tuesday, killing one of those handing out doses and two policemen, while a child was injured, officials said, but there was no immediate claim of responsibility. The attack in the northwest region bordering Afghanistan comes a day after Pakistan launched its latest national campaign to s...

Nigeria Says at Current Rate, Monkeypox Infections in 2022 Could Be Highest in 5 Years
https://www.medscape.com/viewarticle/976303

Jun 29th, 2022 - LAGOS (Reuters) - Confirmed cases of monkeypox in Nigeria could reach their highest level in five years if the current trend of infections is maintained, the head of the country's centre for disease control said on Tuesday. Nigeria is one of the countries in Africa where monkeypox is endemic. Monkeypox occurs when a person comes in contact with the virus from another person, animal or contamina...

Diabetes Tied to Risk of Long COVID, Too
https://www.medscape.com/viewarticle/976349

Jun 29th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Individuals with diabetes who experience COVID-19 are at increased risk for long COVID compared to individuals without diabetes, according to data from a literature review of seven studies. Diabetes remains a risk factor for severe COVID-19, but whether it is a risk factor for postacute sequelae...

Opioids May Cause More Harm Than Good After Mild to Moderate Surgery
https://www.medscape.com/viewarticle/976379

Jun 29th, 2022 - Opioid prescriptions after minor to moderate surgeries do not reduce pain after patient discharge, according to a new meta-analysis. Researchers also found that patients given opioid prescriptions are at higher risk of adverse events, including vomiting, nausea, and constipation. "The prescription of opioids after surgery is embedded in North America's healthcare culture, while in many other co...

Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma
https://www.mdedge.com/dermatology/article/255804/dermatopathology/chronic-retiform-purpura-abdomen-and-thighs-fatal-case
Nelson Ugwu, MD, Nour Kibbi, MD et. al.

Jun 28th, 2022 - To the Editor: Intravascular large cell lymphoma (ILCL) is a rare B-cell lymphoma that is defined by the presence of large neoplastic B cells in the lumen of blood vessels. 1 At least 3 variants of ILCL have been described based on case reports and a small case series: classic, cutaneous, and hemophagocytic.

COVID was twice as deadly in poorer countries
https://www.nature.com/articles/d41586-022-01767-z
Nature Guglielmi G.

Jun 28th, 2022 - Early in the COVID-19 pandemic, the risk of dying from the disease was roughly twice as high for people living in lower-income countries as for those in rich nations, a study reports. The research, published in BMJ Global Health in May1, is one of a growing number of studies to reveal COVID-19’s massive burden in lower-income countries.

Is the pediatric hepatitis outbreak real? A top WHO physician weighs in
https://www.science.org/content/article/pediatric-hepatitis-outbreak-real-top-who-physician-weighs
Science Wadman M.

Jun 28th, 2022 - It has been 3 months since the United Kingdom reported severe, unexplained hepatitis was sending young children to hospitals in unusual numbers. The initial handful of cases reported in Scotland on 31 March were soon joined by dozens and then hundreds, primarily from Europe, the United States, and the United Kingdom. As of 22 June, the global total, from 33 countries, has swollen to 920 probabl...

Study reveals how Duchenne muscular dystrophy causes heart rhythm problems
https://www.eurekalert.org/news-releases/957276

Jun 28th, 2022 - The results help explain why as many as 60% of patients with DMD have potentially life-threatening heart rhythm abnormalities. They may also suggest potential treatment strategies for heart problems in people with DMD. Mutations in a gene that encodes a muscle-protecting protein called dystrophin cause DMD. The condition disproportionately affects males who inherit one copy of the abnormal gene...

Precision antibacterials
https://www.eurekalert.org/news-releases/957244

Jun 28th, 2022 - In the fight against the Covid-19 pandemic, mRNA-based vaccines have impressively demonstrated their potential. Using this technology, scientists were able to rapidly develop and bring to market vaccines against SARS-CoV-2 that have been extremely effective at protecting millions of people against severe disease progression of COVID-19 or even death. However, RNA-based medicine can be used to c...

Monkeypox and COVID: Public Health Has to Increase Trust
https://www.medscape.com/viewarticle/976081

Jun 28th, 2022 - As a long-standing HIV doctor (where we use harm reduction messaging as a matter of course), I have watched with interest the excellent messaging by the Centers for Disease Control and Prevention (CDC) on monkeypox and contrasted that with the "abstinence only" messaging that occurred with COVID-19. Harm reduction messaging — which incorporates the needs of individuals while working to minimize...